Wahren: Elevating Healthcare Standards through Top-Notch Pharmaceutical Packagings

Deepanshu Goel, Managing Director

Deepanshu Goel

Managing Director

The pharmaceutical packaging industry has evolved rapidly to cater to the global demand for Indian medicine. Indian pharma companies operating on domestic and international platforms are under pressure to meet strict regulation standards. Conse­quently, this brought about adopting advanced packing materials that offer better protection against environmental factors. Additionally, there is an increasing focus on sustainable pack­aging options to maintain the drugs' integrity and efficacy during transit and storage. Nev­ertheless, stringent regulatory requirements, sustainability concerns, supply chain break­downs, counterfeiting, and managing costs are some challenges faced by clients in this sector. Wahren is a well-established company providing high-quality, innovative pharmaceutical packag­ing solutions globally. The company has succeed­ed in meeting customers' needs by using modern technologies for compliance with international standards, developing environmentally friendly substances, maintaining effective distribution networks, integrating security features against counterfeit, and optimizing production meth­ods.

Since its inception, Wahren has been committed to changing the face of pharmaceutical packaging by providing inventive and high-standard solutions. Established to ensure that medicines are safe and effective, the company has consistently exceeded industry norms and thus gained global trust as a partner for pharmaceutical companies. Since its formation, Wahren has pursued customer satisfaction by using tailored packaging options that meet strict regulatory requirements. The firm's team of experts works closely with clients to provide exceptional service and develop custom-made solutions to unique client needs. To stay ahead of the game regarding its technology, research, and development investment, the firm has always been cutting edge; hence, it continues to deliver excellent package solutions that exceed customers' expectations. The company has become known for its perfectionism and insistence on compliance, making it a reliable leader in the field. Wahern's activities are based on adherence to international regulatory standards. Additionally, it holds Drug Master File (DMF) certifications in China, the United States (US), and Canada, alongside Good Manufacturing Practice (GMP) certification. “These certifications underscore Wahren's commitment to meeting stringent regulatory requirements, providing secure and safe packaging solutions for medicines”, says Deepanshu Goel, Managing Director.

Pioneering Pharmaceutical Packaging Excellence

Wahren has a complete range of products and services used in the pharmaceutical packaging industry. Its product range includes precision-forming pharmaceutical pack films with advanced adhesive lamination processes. The company cooperates with the customers closely to meet their specific needs for packaging as well as regulatory requirements. It starts by understanding the client's market, product, and other specifics, such as the type of medicine, regulation demands, and distribution conditions. Consequently, an expert team and clients create packaging to satisfy these criteria.

is a leading pharmaceutical packaging manufacturer committed to compliance, innovation, and enhancing global healthcare standards

Deepanshu Goel, Managing Director

“Pharmaceutical packaging must comply with rigorous quality and safety standards to ensure the integrity and efficacy of medicines during transit and storage. This has led to the adoption of advanced packaging materials and technologies designed to provide superior protection against environmental factors such as moisture, light, and oxygen. Innovations like alu alu foil packaging have become increasingly prevalent due to their excellent barrier properties, which safeguard sensitive medications from degradation. Wahren invests in advanced technologies and rigorous testing protocols to ensure that its Alu Alu foils meet and exceed international regulatory standards. This commitment to quality ensures the safety and effectiveness of packaged pharmaceuticals”, briefs Deepanshu.

The production line has Futec's optical flaw inspection system from Japan for quality control purposes, which also removes defects such as fish eyes, foreign bodies, and pinholes to ensure zero defect products. Extensive testing and validation are carried out to ensure that packaging meets demanding performance and quality requirements. Continuous improvement in systems, processes, and skills guarantees the timely delivery of flawless products at competitive costs. Compliance with legislation and standards ensures transparent communication with stakeholders, including suppliers and customers. Regular review and updates of the quality policy reinforce its effectiveness throughout the organization.

Setting the Benchmark in Pharma Packaging Excellence

Wahren stands out in the pharmaceutical packaging industry due to its advanced production capabilities, rigorous quality control, and commitment to sustainability and compliance. The company's state-of-the-art production facility has advanced Air Handling Units (AHUs) that ensure precise control over humidity and temperature, creating optimal working conditions for producing high-quality pharmaceutical packaging solutions. The firm's sophisticated solvent-based lamination process, powered by world-class machinery, guarantees unparalleled precision and consistency in producing Cold Form pharmaceutical packaging films.

The company's comprehensive in-house testing laboratories further support this meticulous approach. These labs are equipped with advanced testing equipments. Additionally, the integration of Kamph Technology ensures efficient aluminum foil slitting, enhancing the accuracy and efficiency of the converting process.

Sustainability is deeply integrated into the firm's operations and product offerings. The company prioritizes environmental stewardship by minimizing its impact on the planet while maximizing the efficacy of its products. Strict waste management practices ensure responsible disposal of manufacturing byproducts, and eco-friendly packaging materials are prioritized. Wahren's dedication to sustainability also involves continuously exploring new technologies and recycling initiatives, highlighting the company's commitment to creating a healthier planet for future generations. This holistic approach to sustainability and unwavering adherence to regulatory compliance positions the firm as a leader in the pharmaceutical packaging industry, distinguished by its innovation, quality, and environmental responsibility.

Wahren envisions becoming a trusted pharmaceutical packaging manufacturer, exceeding customer expectations and enhancing industry standards. The company is grounded in compliance and integrity and aims for customer delight through innovative technologies and R&D investment. The company contributes to elevating global healthcare standards by prioritizing safety and effectiveness. "With a focus on customer-centricity and a dedication to innovation, Wahren is poised to shape the future of pharmaceutical packaging, setting new benchmarks for quality, reliability, and sustainability”, signs off Deepanshu.

on the deck


Most Viewed

Addressing Antimicrobial Resistance (AMR) Through Collaborative Efforts Fostering a Quality Culture in the Pharmaceutical Industry Advancements in Computer-Aided Drug Design for Pharmaceutical Research Why India is Gaining Popularity for Clinical Trials The Future of Kidney Transplants in India Usage of Conversational AI in the Health Insurance Sector Strategies for India to Reduce Its API Dependence on China Business Impact of USFDA Approvals on Indian Pharma Companies Innovative Strategies for Expanding Access to Life Saving Healthcare Solutions Badhal Village Crisis: How Rapid Diagnostics Could Have Saved Lives Why India is a Hotspot for Biotech Startups? Why Adapting Flexibility in IP Rights will Drive Generics Market Meeting the Challenges of High-Potency API (HPAPI) Production Impact of Human Factors Engineering on Medical Device Safety The Future of Pharma: Embracing Continuous Manufacturing The Role of Orphan Drugs in Treating Rare Diseases Emerging Technologies Shaping the Future of Drug Formulation Strategies for Optimizing Pharmaceutical Supply Chain Efficiency The Future of Medicine: Harnessing the Power of RNA-based Therapeutics AI in Medicine: Unmasking the Myths and Embracing the Transformative Reality Cycle Pharma Acquires Banner Life Sciences WHO's First-ever Global Summit on Traditional Medicine Starts in Gujarat The Importance of Data Integrity in Pharmaceutical Quality Control DCGI in Talks with Stakeholders to Develop a Standardised Web Platform to Assure Drug Quality and Patient Safety Glenmark Pharmaceuticals secures ANDA Nod for 0.03 per cent Tacrolimus Ointment Streamlining Laboratory Operations with a Modern LIMS Healthtech Start-up Suraksha QR Ropes In Actor Murali Sharma as its Brand Ambassador Unlocking the Potential of Pharmacogenomics: Enhancing Drug Safety and Efficacy The Impact of Pharmaceutical Testing on Drug Development India has Identified Three Health Priorities to Strengthen Global Health Infrastructure, says WHO National Health Authority launches 100 Microsites Project to Speed Up Digital Health Adoption India Should Partner with Australia to avail PBS for the Selection, Listing, and Pricing processes of exported drugs, says Sudarshan Jain Zydus Lifesciences India More than Doubles Profit Due to Increased Sales in the US India Triples Organ Donations over Past Decade says Union health minister Mansukh Mandaviya Advent Therapeutics Awarded $3 Million NIH Grant For Novel Neonatal Lung Therapy Three Pharma Marketing Strategies That Drive Sales Novartis Targets India's Rare Disease Market with 17 Clinical Programs UK Health Regulator approves GSK's Vaccine for the common respiratory virus RSV WHO Urges Increased Use Of Recommended Malaria-Fighting Tools Karnataka Budget Offered a Significant Boost to Health & Lifesciences Start-ups with Focus on Infrastructure & Innovation Three High Potential Moonshot Project Areas in Pharma CCI approves Bharat Biotech International-Eastman Exports deal How Biotech is Revolutionizing the Fight Against Cancer LifeCell and HaystackAnalytics ink strategic pact to scale-up TB whole genome sequencing pan-India Mankind Pharma IPO To Open On April 25 With A Price Fixed At Rs 1,026-1,080 Per Share US CDC Approves Second Omicron-Updated COVID Booster For Adults Three Trends that will Impact Pharmaceutical Industry in 2023 ModeX Therapeutics Commences Phase I EBV Vaccine Trial with Merck Designing Impactful Leadership and Talent Management Programs with Strategies for Success Novo Nordisk and Valo Health Partner to develop novel Treatments FOPE Calls for Extended Deadline for Schedule M Compliance Telix Pharma To Acquire ImaginAb to Boost Therapeutics and Innovation Roche Secures US FDA Approval for its Ultra-Sensitive ISH test Rappta Therapeutics and SpringWorks Partner on Molecular Glue Targeting PP2A Taro Pharma To Acquire entire stake in Antibe Therapeutics Innovent Biologics Secures Breakthrough Therapy Designation for IBI343 Emcure Pharma Launches Largest R&D Centre in Ahmedabad Zydus Bags USFDA Nod for Phase II(b) Trial to Optimize Usnoflast Dosage US FDA Approves Amgen's Lumakras-Vectibix Combo for KRAS G12C-Mutated mCRC Glenmark Pharma Unveils generic anticoagulant injectable emulsion Strides Pharma Bags USFDA Nod for OTC Acetaminophen-Ibuprofen Combo Tablets US FDA Lifts Hold on Sanofi's Trial to Make Cialis Available Over-the-Counter Hoth Therapeutics Expands Intellectual Property with New Patents Jaguar Health Starts POC Trial of Crofelemer for Rare Pediatric Disease MVID Pharma and Healthcare Sector Eyes Union Budget 2025 for Innovation Boost How Innovative Drug Formulations are Enhancing Treatment Outcomes Apollo and Mayapada Healthcare Unite to Boost Indonesia's Healthcare Novo Nordisk Reports Positive Phase 1b/2a Results for Amycretin Govt to Extend Schedule M Compliance Deadline for Drug Manufacturers to Dec Lupin Secures US FDA Nod for Ipratropium Bromide Nasal Solution ANDA Granules Pharmaceuticals Secures USFDA Nod for Key Generic Drug Bajaj Healthcare Bags DCGI Nod to Manufacture Pimavanserin API & Formulation Union Budget 2025: Healthcare Gets 9.78% Boost, Allocation Nears 1 Lakh Crore Metropolis & Roche Launch Self-Sampling HPV Test for Cervical Cancer Sigachi Industries Invests $1M in Hyderabad R&D Hub for API Innovation Pharma Testing Market Surges with Rising Demand for Biologics ISTH Releases Clinical Practice Guideline For Haemophilia Treatment Sanofi and Biovac Lead Polio Vaccine Manufacturing Capabilities Sun Pharma and Takeda Ink Pact To Market Gastrointestinal Drug Takeda and Ascentage Pharma Ink Option Agreement For Olverembatinib Enhancing Compliance through Effective Pharmaceutical Regulatory Affairs Strategies India poised to become a Global Hub for Clinical Trials: Exec SCHOTT Pharma Unveils Next-Gen Polymer Syringes for Enhanced Safety GSK's Jemperli Gains EU Nod for First-Line Treatment of Endometrial Cancer Union Health Secretary Urges Stronger Drug Regulations for Quality Control Telangana Govt Inks Landmark Deals to Propel Life Sciences and Job Growth R&D in Indian Pharma: Breakthroughs and Innovations in 2024 Dr. Reddy's Partners with Shanghai Henlius to Develop Cancer Drug Uniphar Expands Global Footprint with Three New Facilities 74th Indian Pharmaceutical Congress 2025 Opens Registrations AGC Pharma Expands HPAPI Capabilities in Barcelona to Meet Growing Demand The Future of Genomic Sequencing: Trends That Will Define the Next Decade Lexaria Bioscience Ethics Review Board Nod to Commence New GLP-1 Study Amitabh Kant Urges India to Focus on Innovation at BioAsia 2025 Government Enhances Research & Integration Initiatives in Unani Medicine Blind & Deaf individuals face Major Barriers to access Medicines: Report C-CAMP and PariSante Campus launched Indo-French Life Sciences Hub Jaguar Health Begins Pediatric Trial for Crofelemer in Short Bowel Syndrome Algiax Pharma Reports Promising Phase 2a Results for AP-325 Govt Bans 34 Antimicrobials for Use in Animals Pharmaceutical Procurement Strategies: How to Optimize Costs Personalized Medicine: Get Tailored Treatment Plans for You Now How to Bridge the Healthcare Gap in Emerging Markets with MedTech The Evolution of In-Vitro Diagnostics: Trends and Future Prospects Needle-Free Injection System: A Game Changer in Less Pain Vaccination How Global Capability Centers are Shaping the Future of Biometrics Building a Successful Pharma Brand in India: The Role of Scientific Communication Unlocking India's Innovation Potential in Pharma The Future of Green Chemistry in API Production Top 10 Pharmaceutical Recruitment Consultants - 2024 | Pharma Outlook Blockchain for Secure Pharmaceutical Supply Chains - 2025 & Beyond Mass Spectrometry in Biomarker Discovery for Early Disease Detection Iconovo and Lonza Team up to Advance Intranasal Biologic with ICOone Nasal Fetal Imaging to Cardiac Diagnosis: The Expanding Role of Ultrasound Balancing Innovation and Affordability in Medical Solutions for India Changing Landscape for LTBI and Syndromic Testing Methodologies How Advanced Training Methods can Enhance Patient Care Balancing Cost Efficiency and Compliance in Pharmaceutical Manufacturing LUB Urges Govt to Scrap Mandatory Lab Testing for Cough Syrup Exports Role of Optical Imaging in Early Cancer Detection and Treatment Hoth Therapeutics Unveils Promising Data for KIT-Targeting Therapy Pharmexcil Engages ASEAN Nations to Boost Pharma Trade Ties Fortis Partners with Teleflex for South Asia UroLift Training Anti-Infectives: How New Research is Shaping Infection Control Building Bridges for Sustainable Growth through Strategic Alliances in Ethical Pharmaceuticals Quality as the Cornerstone of Lab Solutions FDA Approves Roch's NSCLC Diagnostic Linked to Emrelis How Early Detection is Transforming Cancer Treatment in India Ensuring Data Privacy in Pharma World Enhancing Clinical Trial Supply Chain Resilience to Address Global Disruptions in India Cost-Effectiveness of Minimally Invasive Surgery in Outpatient Settings How Organic Synthesis is Accelerating Drug Discovery in Pharma Strategic finance for pharmaceutical innovation and stability Top 10 Teleradiology Service Providers - 2024 | Pharma Outlook Importance of Investing in R&D and Quality for Competitive Advantage in Eye Care Top 10 In Vitro Diagnostics Companies - 2024 | Pharma Outlook Phytopharmaceuticals: Driving Global Herbal Medicine Innovation Gender Gap in Healthcare: Why Women's Health Needs More Research Impact of Modern Technology on the Indian Life Sciences Sector Why Global Pharma Expects CDMOs to Be Ready for Joint Inspections The Role of Customizable Stent Grafts for Treating Complex Anatomies Nutraceuticals vs Pharmaceuticals: Complementary or Alternative in Chronic Disease Management? Top 10 Pharma CDMO Companies In India – 2023 | Pharma Outlook Leaping Towards Global Compliance with Revised Schedule M Meril Concludes TechVentory, Boosts AI-Driven Healthcare Supply Chains 10 Pharma Sector Revolutions in India Standardizing Medicine Labeling and Embracing Digital Transformation Creating a patient-centric healthcare ecosystem for all Biomanufacturing of Enzymes: A Sustainable Approach to Industrial Biotechnology Integrating CSR into HR Practices to Enhance Brand Reputation in Pharma Merck Launches Phase 3 Trial for Promising Dengue Vaccine V181 Breakthrough: Eye-Opening Healthcare Strategies Doctors Swear By on Doctor's Day 2025 Bristol Myers Squibb Reports Strong Phase 3 Results for Deucravacitinib trail Alcon Launches Innovative Daily Lenses Designed for Long-lasting Comfort Apisolex Excipient by Lubrizol Backs Phase I Drug Success FDA Approves Enflonsia to Prevent RSV in Infants with One Dose Biosimilars in India 2025 Market Trends, Growth Forecast & Opportunities How Regulations Are Shaping India's Medical Device Landscape Bharat Biotech Partners with GSK for Shigella Vaccine Development Eli Lilly Obesity Drug Shows 11.5% Weight Loss in 12 Weeks Laborate Pharmaceuticals: Illuminating Pathways Of Quality, Affordability Innovation In Healthcare Sun Pharma Bags CDSCO Approval to Produce Fexuprazan Hydrochloride Tablets The Fusion of Biology, Medicine, Health, and AI Glenmark Gets DCGI Nod to Launch Oncology Drug BRUKINSA in India Kyndryl Partners with Dr Reddys to Automate Global IT Operations How Robotic Assisted Surgery Is Redefining Precision in Kidney Transplants Top 10 Women Disruptors in Asia Pharmaceutical Industry

Editor's Guest


© 2026 India Pharma Outlook. All Rights Reserved.